A trial‐based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome

BACKGROUND: Irritable Bowel Syndrome (IBS) is a prevalent, chronic gastrointestinal disorder that imposes a substantial socioeconomic burden. Peppermint oil is a frequently used treatment for IBS, but evidence about cost‐effectiveness is lacking. OBJECTIVE: We aimed to assess cost‐effectiveness of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Weerts, Zsa Zsa R. M., Essers, Brigitte A. B., Jonkers, Daisy M. A. E., Willems, Jeresa I. A., Janssen, Deborah J. P. A., Witteman, Ben J. M., Clemens, Cees H. M., Westendorp, Audrey, Masclee, Ad A. M., Keszthelyi, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Neurogastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598953/
https://www.ncbi.nlm.nih.gov/pubmed/34468079
http://dx.doi.org/10.1002/ueg2.12134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598953/
https://www.ncbi.nlm.nih.gov/pubmed/34468079
http://dx.doi.org/10.1002/ueg2.12134

Ejemplares similares